Skip to main content

Peer Review reports

From: Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial

Original Submission
16 Mar 2020 Submitted Original manuscript
24 Mar 2020 Reviewed Reviewer Report - Alice Sitch
25 Mar 2020 Reviewed Reviewer Report - Kirsty Loudon
27 Mar 2020 Reviewed Reviewer Report - Charles Weijer
29 Mar 2020 Reviewed Reviewer Report - Michael J. Grayling
1 Apr 2020 Reviewed Reviewer Report - Graeme MacLennan
1 Apr 2020 Reviewed Reviewer Report - Steven Julious
15 May 2020 Author responded Author comments - Bang-Jiang Fang
Resubmission - Version 2
15 May 2020 Submitted Manuscript version 2
22 May 2020 Reviewed Reviewer Report - Kirsty Loudon
23 May 2020 Reviewed Reviewer Report - Charles Weijer
30 May 2020 Reviewed Reviewer Report - Michael J. Grayling
5 Jun 2020 Author responded Author comments - Bang-Jiang Fang
Resubmission - Version 3
5 Jun 2020 Submitted Manuscript version 3
Publishing
10 Jun 2020 Editorially accepted
24 Jun 2020 Article published 10.1186/s13063-020-04498-6

You can find further information about peer review here.

Back to article page